Shizuru Judith Anne

Shizuru Judith Anne is listed in filings as Director at Jasper Therapeutics, Inc.. This profile follows SEC Form 4 activity through Sep 24, 2025, including purchase activity. Recent filings connect the profile to Jasper Therapeutics, Inc. (JSPR). The current snapshot covers public activity from Jul 3, 2025 to Sep 24, 2025. Reported amounts are shown as $50.8K to $99.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.